BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 9554156)

  • 1. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
    Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Limited role of naltrexone in the treatment of opiate addiction].
    van Brussel GH
    Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
    Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R
    Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
    Gold MS; Dackis CA; Washton AM
    Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
    McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
    Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels.
    Foster J; Brewer C; Steele T
    Addict Biol; 2003 Jun; 8(2):211-7. PubMed ID: 12850780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone in addicted physicians and business executives.
    Washton AM; Gold MS; Pottash AC
    NIDA Res Monogr; 1984; 55():185-90. PubMed ID: 6443377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the National Institute on Drug Abuse in the development of naltrexone.
    Ginzburg HM; Glass WJ
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid opiate detoxification. Assessment is needed to exclude certain patients before detoxification.
    Rumball D; Williams J
    BMJ; 1997 Sep; 315(7109):682. PubMed ID: 9310588
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clonidine-naltrexone: a new technic for the detoxification of opiate addicts].
    Oliveros SC; Caballero L; Iruela LM
    Med Clin (Barc); 1990 Nov; 95(16):627-9. PubMed ID: 2097456
    [No Abstract]   [Full Text] [Related]  

  • 13. Contemporary methods in pharmacotherapy in the opiate dependent treatment.
    Radomska M; Bisaga A; Popik P
    Przegl Lek; 2000; 57(10):509-18. PubMed ID: 11199877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Narcotic antagonists in drug dependence: pilot study showing enhancement of compliance with SYN-10, amino-acid precursors and enkephalinase inhibition therapy.
    Chen TJ; Blum K; Payte JT; Schoolfield J; Hopper D; Stanford M; Braverman ER
    Med Hypotheses; 2004; 63(3):538-48. PubMed ID: 15288384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term relapse of ultra-rapid opioid detoxification.
    Salimi A; Safari F; Mohajerani SA; Hashemian M; Kolahi AA; Mottaghi K
    J Addict Dis; 2014; 33(1):33-40. PubMed ID: 24471478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of opioid antagonists and psychosocial therapy in the treatment of narcotic and alcohol dependence.
    O'Malley SS
    J Clin Psychiatry; 1995; 56 Suppl 7():30-8. PubMed ID: 7673103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year follow-up of opiate addicts with naltrexone and behavior therapy.
    Rawson RA; Tennant FS
    NIDA Res Monogr; 1984 Mar; 49():289-95. PubMed ID: 6434974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient opiate detoxification with clonidine.
    Washton AM; Resnick RB
    J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
    Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
    J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative strategies of opiate detoxification: evaluation of the so-called ultra-rapid detoxification.
    Scherbaum N; Klein S; Kaube H; Kienbaum P; Peters J; Gastpar M
    Pharmacopsychiatry; 1998 Nov; 31(6):205-9. PubMed ID: 9930633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.